Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 4 | 3 | 3 | 1 |
| Receivables | 5 | 12 | 6 | 16 | 16 |
| TOTAL | $11 | $15 | $21 | $31 | $29 |
| Non-Current Assets | |||||
| PPE Net | 255 | 289 | 385 | 389 | 396 |
| Investments And Advances | 56 | 52 | 55 | 52 | 52 |
| TOTAL | $311 | $341 | $440 | $442 | $448 |
| Total Assets | $322 | $356 | $461 | $473 | $478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 66 | 93 | 169 | 281 | 248 |
| Accounts payable and accrued liabilities | 131 | 252 | 355 | 268 | 294 |
| Accrued Expenses | 35 | 28 | 1 | 16 | 4 |
| TOTAL | $247 | $388 | $539 | $580 | $561 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 63 | 191 | 76 | 24 | 21 |
| TOTAL | $63 | $191 | $76 | $24 | $21 |
| Total Liabilities | $310 | $578 | $615 | $603 | $582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,739 | 7,634 | 35,320 | 30,720 | 28,020 |
| Common Shares | 9 | 0 | 3 | 3 | 0 |
| Retained earnings | -4,442 | -4,153 | -3,887 | -3,582 | -3,357 |
| Other shareholders' equity | 21 | 17 | 20 | 17 | 17 |
| TOTAL | $13 | $-222 | $-154 | $-130 | $-104 |
| Total Liabilities And Equity | $322 | $356 | $461 | $473 | $478 |